Knowles Margaret
Knowles Margaret
Verified email at
Cited by
Cited by
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
MA Knowles, CD Hurst
Nature reviews cancer 15 (1), 25-41, 2015
Intragenic ERBB2 kinase mutations in tumours
P Stephens, C Hunter, G Bignell, S Edkins, H Davies, J Teague, ...
Nature 431 (7008), 525-526, 2004
Bladder cancer
O Sanli, J Dobruch, MA Knowles, M Burger, M Alemozaffar, ME Nielsen, ...
Nature reviews Disease primers 3 (1), 1-19, 2017
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
N Rothman, M Garcia-Closas, N Chatterjee, N Malats, X Wu, JD Figueroa, ...
Nature genetics 42 (11), 978-984, 2010
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
LA Kiemeney, S Thorlacius, P Sulem, F Geller, KKH Aben, SN Stacey, ...
Nature genetics 40 (11), 1307-1312, 2008
IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors
FE Bleeker, S Lamba, S Leenstra, D Troost, T Hulsebos, WP Vandertop, ...
Human mutation 30 (1), 7-11, 2009
Oncogenic FGFR3 gene fusions in bladder cancer
SV Williams, CD Hurst, MA Knowles
Human molecular genetics 22 (4), 795-803, 2013
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
AH Jebar, CD Hurst, DC Tomlinson, C Johnston, CF Taylor, MA Knowles
Oncogene 24 (33), 5218-5225, 2005
Distinct microRNA alterations characterize high-and low-grade bladder cancer
JWF Catto, S Miah, HC Owen, H Bryant, K Myers, E Dudziec, S Larré, ...
Cancer research 69 (21), 8472-8481, 2009
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
DC Tomlinson, O Baldo, P Harnden, MA Knowles
The Journal of pathology 213 (1), 91-98, 2007
Allelotype of human bladder cancer
MA Knowles, PA Elder, M Williamson, JP Cairns, ME Shaw, MG Law
Cancer research 54 (2), 531-538, 1994
Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer
RE Banks, P Tirukonda, C Taylor, N Hornigold, D Astuti, D Cohen, ...
Cancer research 66 (4), 2000-2011, 2006
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
MA Knowles
Carcinogenesis 27 (3), 361-373, 2006
A germline deletion of p14ARF but not CDKN2A in a melanoma–neural system tumour syndrome family
JA Randerson-Moor, M Harland, S Williams, D Cuthbert-Heavens, ...
Human molecular genetics 10 (1), 55-62, 2001
Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer
FM Platt, CD Hurst, CF Taylor, WM Gregory, P Harnden, MA Knowles
Clinical cancer research 15 (19), 6008-6017, 2009
What is cancer
LM Franks, MA Knowles
Introduction to the cellular and molecular biology of cancer 4, 4-9, 2005
Proteomic changes in renal cancer and co‐ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect
RD Unwin, RA Craven, P Harnden, S Hanrahan, N Totty, M Knowles, ...
PROTEOMICS: International Edition 3 (8), 1620-1632, 2003
DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene
JL Kissil, E Feinstein, O Cohen, PA Jones, YC Tsai, MA Knowles, ...
Oncogene 15 (4), 403-407, 1997
Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
P Cairns, ME Shaw, MA Knowles
Oncogene 8 (4), 1083-1085, 1993
Genomic subtypes of non-invasive bladder cancer with distinct metabolic profile and female gender bias in KDM6A mutation frequency
CD Hurst, O Alder, FM Platt, A Droop, LF Stead, JE Burns, GJ Burghel, ...
Cancer cell 32 (5), 701-715. e7, 2017
The system can't perform the operation now. Try again later.
Articles 1–20